经导管与外科生物瓣主动脉瓣临床小叶血栓的四维计算机断层扫描评估
本研究对2015年10月至2017年1月在本机构因临床或超声心动图指征怀疑小叶血栓而接受四维计算机断层扫描(4DCT)的55例经导管主动脉瓣置换(TAVR)和46例外科主动脉瓣置换(SAVR)患者进行评估。4DCT显示TAVR患者小叶血栓发生率为30.9%(17/55),SAVR患者为32.6%(15/46)。抗凝治疗后随访4DCT显示所有TAVR患者和三分之二SAVR患者的血栓负荷及瓣叶活动改善或消退。
要点
- 临床或超声心动图怀疑小叶血栓的患者中,约三分之一经4DCT证实存在小叶血栓。
- TAVR患者小叶血栓发生率为30.9%(17/55),SAVR患者为32.6%(15/46)。
- 抗凝治疗后随访4DCT显示所有TAVR患者和三分之二SAVR患者血栓负荷及瓣叶活动改善或消退。
核心结论
- 在临床或超声心动图提示小叶血栓的患者中,约三分之一经4DCT发现小叶血栓证据。
- 这允许制定个体化抗凝治疗,使大多数患者血栓消退,并避免其余三分之二患者不必要的抗凝。
研究设计与样本
- 回顾性评估2015年10月至2017年1月在本机构接受TAVR或SAVR并有临床或超声心动图小叶血栓指征的患者,均行4DCT检查。
- 研究期间共有612例患者接受TAVR,其中101例(55例TAVR,46例SAVR)符合4DCT成像标准。
主要发现
- TAVR患者小叶血栓发生率为30.9%(17/55),SAVR患者为32.6%(15/46)。
- 抗凝治疗后随访4DCT显示,所有TAVR患者和三分之二SAVR患者的血栓负荷及瓣叶活动改善或消退。
关键数值与推荐
- 超声心动图4DCT指征包括:平均跨瓣压差间隔增加≥10 mm Hg、射血分数间隔下降≥10%、经胸超声心动图见血栓、瓣周漏持续或加重、或经胸超声心动图见瓣膜开裂或瓣叶增厚。
- 临床指征包括:卒中、短暂性脑缺血发作、或新发或加重的心力衰竭。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of leaflet thrombosis after transcatheter aortic valve replacement (TAVR) with active surveillance by four-dimensional computed tomography (4DCT) ranges from 7% to 14%. The incidence of leaflet thrombosis when 4DCT is performed for clinical and echocardiographic indications is unknown. METHODS: All patients with prior TAVR or surgical aortic valve replacement (SAVR) who underwent evaluation between October 2015 and January 2017 at our institution and had clinical or echocardiographic indications of leaflet thrombosis were evaluated by 4DCT. Indications for 4DCT by echocardiography included (1) interval increase in mean gradient of 10 mm Hg or more, (2) interval decrease in ejection fraction of 10% or more, (3) thrombus seen on transthoracic echocardiography, (4) persistent or increasing paravalvular leak, or (5) valve dehiscence or thickened leaflets seen on transthoracic echocardiography. Clinical indicators were (1) stroke, (2) transient ischemic attack, or (3) new or worsening heart failure. RESULTS: During the study period, 612 patients underwent TAVR, and 101 patients (55 TAVR; 46 SAVR) met the criteria for 4DCT imaging. Leaflet thrombosis was seen in 17 of 55 TAVR patients (30.9%) and 15 of 46 SAVR patients (32.6%). Follow-up imaging with 4DCT after treatment with anticoagulation showed improvement or resolution in thrombus burden and leaflet excursion in all TAVR patients and in two-thirds of SAVR patients. CONCLUSIONS: One-third of patients with clinical or echocardiographic indications suggestive of leaflet thrombosis were found to have evidence of leaflet thrombosis using 4DCT. This allowed tailored anticoagulation therapy with resolution of the thrombus in most patients and avoiding unnecessary anticoagulation in the remaining two-thirds of patients.
引用
- Basra SS, Gopal A, Hebeler KR, et al. Clinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves by Four-Dimensional Computed Tomography. Ann Thorac Surg. 2018. PMID: 30153438. doi:10.1016/j.athoracsur.2018.05.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。